Landscapes / Companies
Immunome, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
5
in active trials · 6 in all
Trials
6 active
11 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Varegacestatnot checked |
— |
Phase 2/3 | May 2027Phase 1 trial completes | ||
| Next date | May 2027 · Phase 1 trial completes | ||||
| Also tested for | Desmoid, Desmoid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | May 2028Phase 1 trial completes | |||
| Next date | May 2028 · Phase 1 trial completes | ||||
| Also tested for | Solid Malignancies, Hematologic Malignancies | ||||
| Open drug page | |||||
— |
Phase 1 | Jan 2029Phase 1 trial completes | |||
| Next date | Jan 2029 · Phase 1 trial completes | ||||
| Also tested for | Colorectal Cancer, Non-Small Cell Lung Cancer and 4 more | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2029Phase 1 trial completes | |||
| Next date | Dec 2029 · Phase 1 trial completes | ||||
| Also tested for | Solid Malignancies | ||||
| Open drug page | |||||
— |
Phase 1 | Sep 2030Phase 1 trial completes | |||
| Next date | Sep 2030 · Phase 1 trial completes | ||||
| Also tested for | Colorectal Cancer, Non-Small Cell Lung Cancer and 2 more | ||||
| Open drug page | |||||
About
- No active trial
- IMM-BCP-01
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021